Ivabradine/metoprolol - ServierAlternative Names: Metoprolol/ivabradine
Latest Information Update: 06 Nov 2015
At a glance
- Originator Servier
- Class Antihypertensives; Benzazepines; Bradycardic agents; Class II antiarrhythmics; Heart failure therapies; Heterocyclic bicyclo compounds; Ischaemic heart disorder therapies; Propanolamines; Small molecules
- Mechanism of Action Beta 1 adrenergic receptor antagonists; Potassium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Registered Angina pectoris
Most Recent Events
- 06 Nov 2015 Registered for Angina pectoris in Netherlands, Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Latvia, Liechtenstein, Lithuania, Malta, Norway, Poland, Romania, Slovenia, Sweden, Slovakia (PO)